GREGORY WEAVER - 17 Jun 2021 Form 3 Insider Report for ATAI Life Sciences B.V. (ATAI)

Role
Chief Financial Officer
Signature
/s/ Ryan Barrett, Attorney-in-fact
Issuer symbol
ATAI
Transactions as of
17 Jun 2021
Transactions value $
$0
Form type
3
Filing time
17 Jun 2021, 18:08:23 UTC
Previous filing
18 May 2021
Next filing
24 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ATAI Stock Option 17 Jun 2021 Common Shares 880K $2.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 25% of the underlying shares on July 24, 2021, and the remaining underlying shares vest in 36 equal monthly installments thereafter.

Remarks:

Exhibit 24 - Power of Attorney.